|
|
 |
|
Viewing report
|
|
|
|
Company Financials: UCB S.A.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
UCB is a global biopharmaceutical company. The company focuses on severe diseases in the fields of central nervous system (CNS) disorders and autoimmune and inflammatory diseases (AIID). It is headquartered in Brussels, Belgium and employs 11,292 people.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Nektar Therapeutics
Company Financials: Medivation
Company Financials: Genzyme Corporation
Company Financials: Biocryst Pharmaceuticals
Company Financials: Elan Corporation, plc
Company Financials: Isis Pharmaceuticals, Inc.
Company Financials: Genta Incorporated
Company Financials: Genmab A/S
Company Financials: Idenix Pharmaceuticals, Inc.
Company Financials: POZEN, Inc.
|
|
|
|
